about us
 solutions
 services
 clients
 news
 contact
 log in
Mission
Management Team
Partners
Awards
Careers
Customers
Profiles
Contact Us
Directions
Overview
Compliance Plan
Clinical Process Re-Engineering
CTMS Planning Study
Industry Insights
Evaluation & Selection Whitepaper
AtSignOn
adWATCH - AE
adWATCH - CAPA
adWATCH - PCM
adWATCH - SERVICE
ComPac GxP
ECC
Investigator Portal
HATS
paraFILE
Protocol Manager
Training System
Downloads
Feedback Reports
LogOut
 Current Location: Home > Solutions > Protocol Manager - Clinical Trials Management System
   Protocol Manager - Clinical Trials Management System

All Solutions
Quality Management System
 
Security Agent
AtSignOn
 
Pharmaceutical & Medical Device Systems
adWATCH - AE
adWATCH - CAPA
adWATCH - PCM
adWATCH - SERVICE
ComPac GxP
CTMS - Protocol Manager
HATS
Investigator Portal
paraFILE
Training Campus
 
Manufacturing Systems
ECC
 
 



Configurable Options — Protocol Manager is equipped with several configurable options. Some of the options pertain to particular components of Protocol Manager; some options apply to many components simultaneously.

  • Cohort Management — Protocol Manager’s optional cohort processing provides users with the ability to specify cohorts at the patient and subject level. Specific patient visit streams as well as selected CRF page management can be assigned to each cohort. Investigator con-tract processing allows for cohort planning in the Protocols component as well as within the actual clinical trial. Once created, Cohorts allow the project team to easily monitor subjects according to the characteristics they define (age, disease, control group, etc). Expanding on Protocol Manager’s collaborative capabilities all reports are generated in real-time and up-to-date.

  • Cross-Trial CDA Management — The CDA Management component enhances investigator relationship management by allowing the clinical team to track Certificates of Disclosure Agreements (CDAs). This component is designed to track the three types of disclosure agreements; client nondisclosures, vendor non-disclosures, and two-way nondisclosures. Up to the minute information allows project managers to learn the status of all CDAs on demand. Additionally, project managers may determine who signed a CDA and when it was signed.

  • Adverse Events — Adverse Events and Serious Adverse Events must be properly tracked and reported on a trial. Protocol Manger comes enabled with the configurable (optional) ad-Watch-AE safety system. From within this module an adverse event may be reported, encoded, and submitted to the FDA or other health agency electronically.

  • Trial Master File — Protocol Manager provides a configurable link to Winchester’s paraFILE document management and repository system. This option is configured and then exercise when the clinical trial team determines that they wish to “publish” Protocol Manager-managed records, documents, and attached files to the Trial Master File (TMF). Most published documents will be published in the pdf-file format.
Integration Components — Protocol Manager has been interfaced with many other organizations’ software products:

< Back

 
Features and Benefits
Request a Demo
Download Brochure
On-line and off-line use
E-Mail freedom for alerts
21 CFR Part 11 Compliance
Industry Standard Security
Templates for ease of use and efficiency
Powerful Business Development Module
Manages site contracts and payments
Realtime Site Portal
Time & Expense Reporting

Related News
AtSignOn Goes Gold for Lotus Domino and Notes Version 8